Symbols / NEPH Stock $2.84 -0.35% Nephros, Inc.
NEPH (Stock) Chart
About
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
Stock Fundamentals
Scroll to Statements| Market Cap | 30.23M | Enterprise Value | 25.89M | Income | 1.19M | Sales | 18.79M | Book/sh | 0.96 | Cash/sh | 0.51 |
| Dividend Yield | — | Payout | — | Employees | 36 | IPO | — | P/E | 25.82 | Forward P/E | 21.85 |
| PEG | — | P/S | 1.61 | P/B | 2.96 | P/C | — | EV/EBITDA | 20.15 | EV/Sales | 1.38 |
| Quick Ratio | 2.82 | Current Ratio | 4.06 | Debt/Eq | 10.42 | LT Debt/Eq | — | EPS (ttm) | 0.11 | EPS next Y | 0.13 |
| EPS Growth | -82.40% | Revenue Growth | 22.20% | Earnings | 2026-05-07 | ROA | 5.76% | ROE | 12.71% | ROIC | — |
| Gross Margin | 61.87% | Oper. Margin | 0.38% | Profit Margin | 6.35% | Shs Outstand | 10.64M | Shs Float | 9.45M | Short Float | 0.45% |
| Short Ratio | 0.97 | Short Interest | — | 52W High | 6.42 | 52W Low | 1.64 | Beta | 1.56 | Avg Volume | 40.03K |
| Volume | 32.46K | Target Price | $7.00 | Recom | None | Prev Close | $2.85 | Price | $2.84 | Change | -0.35% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-08-08 | main | Maxim Group | Buy → Buy | $6 |
| 2024-11-12 | reit | Benchmark | Speculative Buy → Speculative Buy | $5 |
| 2024-05-15 | reit | Benchmark | Speculative Buy → Speculative Buy | $5 |
| 2024-03-08 | up | Benchmark | Hold → Speculative Buy | $5 |
| 2021-01-26 | init | B. Riley Securities | — → Buy | $13 |
| 2019-10-24 | init | Benchmark | — → Speculative Buy | $16 |
| 2019-10-04 | init | Maxim Group | — → Buy | — |
- Aging water systems push Nephros deeper into the New York market - Stock Titan hu, 16 Apr 2026 13
- 3 Intriguing Penny Stocks With Market Caps At Least $50M - Yahoo Finance Fri, 21 Nov 2025 08
- Is It Time To Consider Buying Nephros, Inc. (NASDAQ:NEPH)? - simplywall.st Wed, 07 Jan 2026 08
- NEPH Stock Analysis: Nephros Inc. 2.21% Dip to $2.87 Med Device Performance Check - UBND thành phố Hải Phòng Fri, 03 Apr 2026 07
- How does earnings affect Nephros (NEPH) Stock | Price at $3.02, Up 3.61% - Retail Flow - Cổng thông tin điện tử tỉnh Tây Ninh Fri, 10 Apr 2026 07
- Is Nephros (NEPH) Stock Stable Now | NEPH Q4 Earnings: Beats Estimates by $0.07 - Upside Surprise - Cổng thông tin điện tử Tỉnh Sơn La Wed, 08 Apr 2026 07
- Hospitals get a new water safety planning option from Nephros - Stock Titan Wed, 01 Apr 2026 07
- Nephros (NEPH) Stock: Technical Trend (Momentum Building) 2026-04-15 - Vega Volatility - Cổng thông tin điện tử Tỉnh Sơn La Wed, 15 Apr 2026 20
- Is Nephros (NEPH) Stock in a Downtrend | Price at $2.82, Down 3.09% - Community Breakout Alerts - Cổng thông tin điện tử tỉnh Lào Cai hu, 09 Apr 2026 07
- Director Arthur Amron receives 3,610 Nephros (NEPH) shares - Stock Titan Wed, 18 Mar 2026 07
- Nephros (NEPH) CFO exercises stock options to acquire 68,861 common shares - Stock Titan Wed, 25 Mar 2026 07
- Nephros (NASDAQ: NEPH) CEO exercises options for 120K shares - Stock Titan Wed, 25 Mar 2026 07
- Nephros (NASDAQ: NEPH) shares updated 2026 corporate presentation with market - Stock Titan Fri, 27 Mar 2026 07
- [Form 4] NEPHROS INC Insider Trading Activity - Stock Titan Wed, 18 Mar 2026 07
- Nephros Releases Updated 2026 Corporate Investor Presentation - The Globe and Mail Sat, 28 Mar 2026 07
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
18.79
+32.67%
|
14.16
-0.53%
|
14.24
+42.74%
|
9.97
|
| Operating Revenue |
|
18.79
+32.67%
|
14.16
-0.53%
|
14.24
+42.74%
|
9.97
|
| Cost Of Revenue |
|
7.16
+31.72%
|
5.44
-6.75%
|
5.83
+11.23%
|
5.24
|
| Reconciled Cost Of Revenue |
|
7.17
+31.78%
|
5.44
-6.79%
|
5.83
+14.13%
|
5.11
|
| Gross Profit |
|
11.62
+33.27%
|
8.72
+3.78%
|
8.40
+77.66%
|
4.73
|
| Operating Expense |
|
10.48
+20.21%
|
8.72
-12.81%
|
10.00
+10.28%
|
9.07
|
| Research And Development |
|
1.34
+47.79%
|
0.91
+3.78%
|
0.87
-30.44%
|
1.25
|
| Selling General And Administration |
|
9.00
+17.25%
|
7.68
-13.86%
|
8.91
+17.36%
|
7.59
|
| Total Expenses |
|
17.64
+24.63%
|
14.16
-10.58%
|
15.83
+10.63%
|
14.31
|
| Operating Income |
|
1.15
+19000.00%
|
0.01
+100.38%
|
-1.59
+63.25%
|
-4.33
|
| Total Operating Income As Reported |
|
1.15
+19000.00%
|
0.01
+100.38%
|
-1.59
+63.25%
|
-4.33
|
| EBITDA |
|
1.35
+493.39%
|
0.23
+116.70%
|
-1.36
+65.21%
|
-3.91
|
| Normalized EBITDA |
|
1.43
+501.27%
|
0.24
+118.02%
|
-1.31
+66.88%
|
-3.97
|
| Reconciled Depreciation |
|
0.14
+1.46%
|
0.14
-35.98%
|
0.21
-39.03%
|
0.35
|
| EBIT |
|
1.21
+1241.11%
|
0.09
+105.72%
|
-1.57
+63.05%
|
-4.26
|
| Total Unusual Items |
|
-0.08
-680.00%
|
-0.01
+77.27%
|
-0.04
-168.75%
|
0.06
|
| Total Unusual Items Excluding Goodwill |
|
-0.08
-680.00%
|
-0.01
+77.27%
|
-0.04
-168.75%
|
0.06
|
| Special Income Charges |
|
—
|
—
|
—
|
0.00
|
| Other Special Charges |
|
—
|
—
|
—
|
—
|
| Restructuring And Mergern Acquisition |
|
—
|
—
|
—
|
—
|
| Net Income |
|
1.19
+1513.51%
|
0.07
+104.70%
|
-1.57
+78.66%
|
-7.38
|
| Pretax Income |
|
1.21
+1255.06%
|
0.09
+105.65%
|
-1.57
+63.18%
|
-4.28
|
| Net Non Operating Interest Income Expense |
|
0.14
+48.39%
|
0.09
+50.00%
|
0.06
+1133.33%
|
-0.01
|
| Interest Expense Non Operating |
|
0.00
+0.00%
|
0.00
-50.00%
|
0.00
-90.00%
|
0.02
|
| Net Interest Income |
|
0.14
+48.39%
|
0.09
+50.00%
|
0.06
+1133.33%
|
-0.01
|
| Interest Expense |
|
0.00
+0.00%
|
0.00
-50.00%
|
0.00
-90.00%
|
0.02
|
| Interest Income Non Operating |
|
0.14
+47.87%
|
0.09
+46.88%
|
0.06
+357.14%
|
0.01
|
| Interest Income |
|
0.14
+47.87%
|
0.09
+46.88%
|
0.06
+357.14%
|
0.01
|
| Other Income Expense |
|
-0.08
-680.00%
|
-0.01
+77.27%
|
-0.04
-168.75%
|
0.06
|
| Other Non Operating Income Expenses |
|
—
|
—
|
-0.04
-168.75%
|
0.06
|
| Gain On Sale Of Security |
|
-0.08
-680.00%
|
-0.01
+77.27%
|
-0.04
-168.75%
|
0.06
|
| Tax Provision |
|
0.01
-20.00%
|
0.01
|
0.00
|
—
|
| Tax Rate For Calcs |
|
0.00
-94.06%
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.00
+53.68%
|
-0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
1.19
+1513.51%
|
0.07
+104.70%
|
-1.57
+77.84%
|
-7.11
|
| Net Income From Continuing Operation Net Minority Interest |
|
1.19
+1513.51%
|
0.07
+104.70%
|
-1.57
+65.41%
|
-4.55
|
| Net Income From Continuing And Discontinued Operation |
|
1.19
+1513.51%
|
0.07
+104.70%
|
-1.57
+78.66%
|
-7.38
|
| Net Income Continuous Operations |
|
1.19
+1513.51%
|
0.07
+104.70%
|
-1.57
+63.18%
|
-4.28
|
| Net Income Discontinuous Operations |
|
—
|
—
|
0.00
+100.00%
|
-2.83
|
| Minority Interests |
|
—
|
—
|
0.00
+100.00%
|
-0.28
|
| Normalized Income |
|
1.27
+1444.01%
|
0.08
+105.38%
|
-1.53
+66.84%
|
-4.62
|
| Net Income Common Stockholders |
|
1.19
+1513.51%
|
0.07
+104.70%
|
-1.57
+78.66%
|
-7.38
|
| Diluted EPS |
|
—
|
0.01
+106.67%
|
-0.15
+78.57%
|
-0.70
|
| Basic EPS |
|
—
|
0.01
+106.67%
|
-0.15
+78.57%
|
-0.70
|
| Basic Average Shares |
|
—
|
10.53
+1.34%
|
10.39
+0.86%
|
10.30
|
| Diluted Average Shares |
|
—
|
10.61
+2.15%
|
10.39
+0.86%
|
10.30
|
| Diluted NI Availto Com Stockholders |
|
1.19
+1513.51%
|
0.07
+104.70%
|
-1.57
+78.66%
|
-7.38
|
| Depreciation Amortization Depletion Income Statement |
|
0.14
+3.70%
|
0.14
-36.92%
|
0.21
-1.83%
|
0.22
|
| Depreciation And Amortization In Income Statement |
|
0.14
+3.70%
|
0.14
-36.92%
|
0.21
-1.83%
|
0.22
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
11.86
|
| Current Assets |
|
8.40
|
| Cash Cash Equivalents And Short Term Investments |
|
4.31
|
| Cash And Cash Equivalents |
|
4.31
|
| Cash Equivalents |
|
4.03
|
| Cash Financial |
|
0.27
|
| Receivables |
|
1.50
|
| Accounts Receivable |
|
1.50
|
| Gross Accounts Receivable |
|
12.50
|
| Allowance For Doubtful Accounts Receivable |
|
-11.00
|
| Inventory |
|
2.47
|
| Raw Materials |
|
0.33
|
| Work In Process |
|
0.00
|
| Finished Goods |
|
2.14
|
| Prepaid Assets |
|
—
|
| Assets Held For Sale Current |
|
—
|
| Other Current Assets |
|
0.13
|
| Total Non Current Assets |
|
3.46
|
| Net PPE |
|
1.96
|
| Gross PPE |
|
2.92
|
| Accumulated Depreciation |
|
-0.96
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.18
|
| Other Properties |
|
2.65
|
| Leases |
|
0.09
|
| Goodwill And Other Intangible Assets |
|
1.41
|
| Goodwill |
|
0.76
|
| Other Intangible Assets |
|
0.65
|
| Other Non Current Assets |
|
0.09
|
| Total Liabilities Net Minority Interest |
|
3.50
|
| Current Liabilities |
|
2.11
|
| Payables And Accrued Expenses |
|
1.67
|
| Payables |
|
0.91
|
| Accounts Payable |
|
0.87
|
| Current Accrued Expenses |
|
0.76
|
| Total Tax Payable |
|
0.04
|
| Current Debt And Capital Lease Obligation |
|
0.45
|
| Current Debt |
|
—
|
| Other Current Borrowings |
|
—
|
| Current Capital Lease Obligation |
|
0.45
|
| Other Current Liabilities |
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
1.39
|
| Liabilities Heldfor Sale Non Current |
|
—
|
| Long Term Debt And Capital Lease Obligation |
|
1.39
|
| Long Term Debt |
|
—
|
| Long Term Capital Lease Obligation |
|
1.39
|
| Stockholders Equity |
|
8.36
|
| Common Stock Equity |
|
8.36
|
| Capital Stock |
|
0.01
|
| Common Stock |
|
0.01
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
10.54
|
| Ordinary Shares Number |
|
10.54
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
152.75
|
| Retained Earnings |
|
-144.41
|
| Gains Losses Not Affecting Retained Earnings |
|
—
|
| Minority Interest |
|
0.00
|
| Total Equity Gross Minority Interest |
|
8.36
|
| Total Capitalization |
|
8.36
|
| Working Capital |
|
6.29
|
| Invested Capital |
|
8.36
|
| Total Debt |
|
1.84
|
| Capital Lease Obligations |
|
1.84
|
| Net Tangible Assets |
|
6.95
|
| Tangible Book Value |
|
6.95
|
| Other Equity Interest |
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
1.65
+434.35%
|
-0.49
-159.49%
|
0.83
+125.57%
|
-3.23
|
| Cash Flow From Continuing Operating Activities |
|
1.65
+434.35%
|
-0.49
-159.49%
|
0.83
+125.57%
|
-3.23
|
| Net Income From Continuing Operations |
|
1.19
+1513.51%
|
0.07
+104.70%
|
-1.57
+77.84%
|
-7.11
|
| Depreciation Amortization Depletion |
|
0.14
+1.46%
|
0.14
-35.98%
|
0.21
-39.03%
|
0.35
|
| Depreciation |
|
0.06
+19.57%
|
0.05
+17.95%
|
0.04
-58.06%
|
0.09
|
| Amortization Cash Flow |
|
0.08
-7.69%
|
0.09
-48.00%
|
0.17
-32.17%
|
0.26
|
| Depreciation And Amortization |
|
0.14
+1.46%
|
0.14
-35.98%
|
0.21
-39.03%
|
0.35
|
| Amortization Of Intangibles |
|
0.08
-7.69%
|
0.09
-48.00%
|
0.17
-32.17%
|
0.26
|
| Other Non Cash Items |
|
0.36
-20.36%
|
0.45
+30.70%
|
0.34
-3.12%
|
0.35
|
| Stock Based Compensation |
|
0.30
+93.46%
|
0.15
-85.46%
|
1.05
+7.13%
|
0.98
|
| Provisionand Write Offof Assets |
|
—
|
0.00
-100.00%
|
0.01
+1200.00%
|
-0.00
|
| Asset Impairment Charge |
|
0.07
-74.05%
|
0.26
-11.19%
|
0.29
-86.39%
|
2.17
|
| Operating Gains Losses |
|
0.01
+145.45%
|
-0.01
|
—
|
-0.06
|
| Net Foreign Currency Exchange Gain Loss |
|
0.01
+183.33%
|
-0.01
|
0.00
+100.00%
|
-0.06
|
| Change In Working Capital |
|
-0.41
+73.42%
|
-1.55
-418.44%
|
0.49
+12.96%
|
0.43
|
| Change In Receivables |
|
-0.63
-122.11%
|
-0.28
-28.96%
|
-0.22
-161.90%
|
0.36
|
| Changes In Account Receivables |
|
-0.63
-122.11%
|
-0.28
-28.96%
|
-0.22
-161.90%
|
0.36
|
| Change In Inventory |
|
-0.69
-68.30%
|
-0.41
-205.17%
|
0.39
-49.41%
|
0.77
|
| Change In Prepaid Assets |
|
-0.04
-250.00%
|
-0.01
-117.86%
|
0.06
+115.38%
|
0.03
|
| Change In Payables And Accrued Expense |
|
1.28
+387.67%
|
-0.45
-169.80%
|
0.64
+186.00%
|
-0.74
|
| Change In Accrued Expense |
|
1.02
+553.10%
|
-0.23
-144.66%
|
0.51
+437.33%
|
-0.15
|
| Change In Payable |
|
0.26
+217.73%
|
-0.22
-265.41%
|
0.13
+122.43%
|
-0.59
|
| Change In Account Payable |
|
0.26
+217.73%
|
-0.22
-265.41%
|
0.13
+122.43%
|
-0.59
|
| Change In Other Current Assets |
|
0.00
-100.00%
|
0.04
+216.13%
|
-0.03
-108.12%
|
0.38
|
| Change In Other Current Liabilities |
|
-0.34
+22.40%
|
-0.44
-29.24%
|
-0.34
+3.66%
|
-0.35
|
| Investing Cash Flow |
|
0.00
+100.00%
|
-0.05
+33.33%
|
-0.07
+45.26%
|
-0.14
|
| Cash Flow From Continuing Investing Activities |
|
0.00
+100.00%
|
-0.05
+33.33%
|
-0.07
+45.26%
|
-0.14
|
| Net PPE Purchase And Sale |
|
0.00
+100.00%
|
-0.05
+33.33%
|
-0.07
+45.26%
|
-0.14
|
| Purchase Of PPE |
|
0.00
+100.00%
|
-0.06
+26.67%
|
-0.07
+45.26%
|
-0.14
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.01
|
0.00
|
—
|
| Capital Expenditure |
|
—
|
-0.06
+26.67%
|
-0.07
+45.26%
|
-0.14
|
| Net Other Investing Changes |
|
—
|
—
|
—
|
—
|
| Financing Cash Flow |
|
-0.01
+0.00%
|
-0.01
+93.67%
|
-0.08
-332.35%
|
0.03
|
| Cash Flow From Continuing Financing Activities |
|
-0.01
+0.00%
|
-0.01
+93.67%
|
-0.08
-332.35%
|
0.03
|
| Net Issuance Payments Of Debt |
|
-0.01
+0.00%
|
-0.01
+93.67%
|
-0.08
+72.38%
|
-0.29
|
| Issuance Of Debt |
|
—
|
—
|
—
|
—
|
| Repayment Of Debt |
|
-0.01
+0.00%
|
-0.01
+93.67%
|
-0.08
+72.38%
|
-0.29
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
-0.01
+0.00%
|
-0.01
+93.67%
|
-0.08
-426.67%
|
-0.01
|
| Net Long Term Debt Issuance |
|
-0.01
+0.00%
|
-0.01
+93.67%
|
-0.08
-426.67%
|
-0.01
|
| Short Term Debt Payments |
|
—
|
—
|
-0.07
+73.80%
|
-0.27
|
| Net Short Term Debt Issuance |
|
—
|
—
|
-0.07
+73.80%
|
-0.27
|
| Net Common Stock Issuance |
|
—
|
—
|
—
|
—
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
0.00
-100.00%
|
0.16
|
| Net Other Financing Charges |
|
—
|
—
|
—
|
0.16
|
| Changes In Cash |
|
1.64
+399.82%
|
-0.55
-181.28%
|
0.67
+120.17%
|
-3.34
|
| Effect Of Exchange Rate Changes |
|
—
|
—
|
0.00
+100.00%
|
-0.00
|
| Beginning Cash Position |
|
3.76
-12.70%
|
4.31
+18.52%
|
3.63
-47.88%
|
6.97
|
| End Cash Position |
|
5.40
+43.62%
|
3.76
-12.70%
|
4.31
+18.52%
|
3.63
|
| Free Cash Flow |
|
1.65
+400.73%
|
-0.55
-172.74%
|
0.75
+122.31%
|
-3.37
|
| Interest Paid Supplemental Data |
|
0.00
-50.00%
|
0.00
+0.00%
|
0.00
-89.47%
|
0.02
|
| Income Tax Paid Supplemental Data |
|
—
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
—
|
—
|
—
|
—
|
| Issuance Of Capital Stock |
|
—
|
—
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-27 View
- 42026-03-25 View
- 42026-03-25 View
- 42026-03-18 View
- 42026-03-18 View
- 10-K2026-03-12 View
- 8-K2025-11-26 View
- 42025-11-13 View
- 42025-11-13 View
- 42025-11-13 View
- 10-Q2025-11-06 View
- 42025-08-13 View
- 8-K2025-08-11 View
- 10-Q2025-08-07 View
- 8-K2025-06-16 View
- 10-Q2025-05-15 View
- 8-K2025-05-08 View
- 8-K2025-04-28 View
- 8-K2025-04-01 View
- 42025-03-31 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|